Novo Nordisk and Valo to research cardiometabolic treatments

Danish drugmaker Novo Nordisk announced it will collaborate with US technology company Valo Health to discover and develop new treatments for cardiometabolic diseases using human data and artificial intelligence.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM